Value of changes of tumor markers in TACE treatment of hepatocellular carcinoma
10.13929/j.1672-8475.201807021
- Author:
Guoqing SU
1
Author Information
1. Department of Intervention, the Second Affiliated Hospital of Harbin Medical University
- Publication Type:Journal Article
- Keywords:
Carcinoma, hepatocellular;
Embolization, therapeutic;
Hepatic artery;
Tumor marker
- From:
Chinese Journal of Interventional Imaging and Therapy
2019;16(1):57-60
- CountryChina
- Language:Chinese
-
Abstract:
Hepatocellular carcinoma (HCC) is one of the most common malignant tumors. Up till now, TACE is the first choice for palliative treatment of HCC. In recent years, a series of metabolites of HCC have been found in the proteome and mRNA groups. The value of common and hot research on tumor markers in HCC for the treatment of TACE were reviewed in this article.
